T-cell subsets in drug-induced toxic epidermal necrolysis. Possible pathogenic mechanism induced by CD8-positive T cells.

Abstract

A patient with bromisovalum-induced toxic epidermal necrolysis showed pronounced delayed hypersensitivity to bromisovalum by patch testing. Biopsy specimens from the cutaneous lesion and the site of the positive patch test reaction were analyzed and compared immunohistologically. The findings were similar: most of the mononuclear cells disposed along the dermoepidermal junction and migrating into the epidermis were CD8-positive lymphocytes, whereas the dermal inflammatory infiltrates were composed predominantly of CD4-positive lymphocytes. This case showed the potential usefulness of patch testing in evaluating cases of toxic epidermal necrolysis. We believe that delayed hypersensitivity plays a crucial role in the development of drug-induced toxic epidermal necrolysis. Furthermore, potential effector cells with phenotypic characteristics of CD8-positive lymphocytes (suppressor/cytotoxic T cells) seem to represent important mediators of the epidermal damage of the cutaneous lesion in our case.

• Authors: H Miyauchi, H Hosokawa, T Akaeda, H Iba, Y Asada
• Journal: Archives of dermatology (Arch Dermatol) Vol. 127 Issue 6 Pg. 851-5 (Jun 1991) ISSN: 0003-987X [Print] United States
• PMID: 2036032 (Publication Type: Case Reports, Journal Article)

Chemical References

• Bromisovalum

Topics

• Adult
• Bromisovalum (adverse effects)
• Humans
• Male
• Patch Tests
• Stevens-Johnson Syndrome (etiology, immunology, pathology)
• T-Lymphocyte Subsets